EasySep™小鼠TIL（CD45）正选试剂盒
A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model.
A combination of DR5 agonistic monoclonal antibody with gemcitabine targets pancreatic cancer stem cells and results in long-term disease control in human pancreatic cancer model.
很抱歉, 生成此内容时发生错误。
沪公网安备31010102008431号